Comment on "Meropenem, Cefepime, and Piperacillin Protein Binding in Patient Samples"

Ther Drug Monit. 2020 Dec;42(6):909-910. doi: 10.1097/FTD.0000000000000809.

Authors

Uwe Liebchen¹, Christoph Dorn², Martin Kees³, Selina Schiesser⁴, Florian Hitzenbichler⁴, Frieder Kees², Michael Paal⁵

Affiliations

¹ Department of Anaesthesiology, University Hospital, LMU Munich, Marchioninistr.
² Institute of Pharmacy, University of Regensburg, Universitätsstr.
³ Departments of Anaesthesiology and.
⁴ Infection Prevention and Infectious Diseases, University Hospital Regensburg, Franz-Josef-Strauß-Allee.
⁵ Institute of Laboratory Medicine, University Hospital, LMU Munich, Marchioninistr, Germany.

PMID: 33186336
DOI: 10.1097/FTD.0000000000000809

No abstract available

Publication types

Comment

MeSH terms

Anti-Bacterial Agents*
Cefepime
Humans
Meropenem
Piperacillin*
Protein Binding
Tazobactam

Substances

Anti-Bacterial Agents
Cefepime
Meropenem
Tazobactam
Piperacillin